Want to see AQB full AI Analyst Report?
AQB Stock Chart & Stats
$0.91
-$0.01(-1.10%)
At close: 4:00 PM EDT
$0.91
-$0.01(-1.10%)
Day’s Range― - ―
52-Week Range$0.70 - $2.95
Previous Close$0.9
Volume12.19K
Average Volume (3M)1.58M
Market Cap
$4.74M
Enterprise Value$7.31
Total Cash (Recent Filing)$440.68K
Total Debt (Recent Filing)$3.80M
Price to Earnings (P/E)―
Beta0.71
Next Earnings
Aug 11, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-5.13
Shares Outstanding5,147,204
10 Day Avg. Volume221,557
30 Day Avg. Volume1,577,744
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)-1.91
Price to Sales (P/S)0.00
P/FCF Ratio>-0.01
Enterprise Value/Market Cap<0.01
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda>-0.01
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-7.28
Revenue Forecast (FY)$500.00K
Bulls Say, Bears Say
Bulls Say
Proprietary Genetics/IPAquaBounty’s focus on genetically engineered Atlantic salmon and retained intellectual property creates a durable competitive asset. Proprietary genetics and breeding know-how can underpin higher biological productivity and provide licensing or strategic-partner opportunities that persist beyond short-term cycles.
Recent Liquidity InfusionThe $2.25M private placement materially extends near-term runway and supports ongoing operations and commercialization efforts. For a cash-burning biotech/aquaculture operator, discrete capital raises are a durable enabler of program continuity and facility operation over the coming months.
Modest Reported DebtReported debt levels are modest in absolute terms, which reduces immediate interest and default pressure. Lower nominal leverage provides structural flexibility to prioritize operational scaling or R&D investment while seeking additional equity or convertible financing if needed.
Bears Say
Persistent Losses & Negative EquitySustained operating and net losses that have eroded equity signal chronic profitability failure. Negative shareholders' equity weakens balance-sheet credibility, constrains financing options, and raises the risk that future capital comes at onerous terms or further dilutes existing shareholders.
Consistent Cash BurnOngoing negative operating and free cash flow indicate the company is burning cash to sustain operations. Persistent cash outflows increase reliance on external funding, compress strategic optionality, and elevate the probability of future financings that can dilute shareholders or impose restrictive covenants.
Inconsistent/no Revenue; Limited Commercial ScaleNear-zero or zero reported revenue across multiple periods shows the business has not achieved stable commercial production or market traction. Without consistent revenue, operating leverage and margin sustainability remain unproven, increasing execution risk and dependence on external capital to reach scale.
AquaBounty Technologies News
AQB FAQ
What was AquaBounty Technologies Inc’s price range in the past 12 months?
AquaBounty Technologies Inc lowest stock price was $0.70 and its highest was $2.95 in the past 12 months.
What is AquaBounty Technologies Inc’s market cap?
AquaBounty Technologies Inc’s market cap is $4.74M.
When is AquaBounty Technologies Inc’s upcoming earnings report date?
AquaBounty Technologies Inc’s upcoming earnings report date is Aug 11, 2026 which is in 12 days.
How were AquaBounty Technologies Inc’s earnings last quarter?
AquaBounty Technologies Inc released its earnings results on Apr 30, 2026. The company reported -$0.263 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is AquaBounty Technologies Inc overvalued?
According to Wall Street analysts AquaBounty Technologies Inc’s price is currently Overvalued.
Does AquaBounty Technologies Inc pay dividends?
AquaBounty Technologies Inc does not currently pay dividends.
What is AquaBounty Technologies Inc’s EPS estimate?
AquaBounty Technologies Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does AquaBounty Technologies Inc have?
AquaBounty Technologies Inc has 5,147,204 shares outstanding.
What happened to AquaBounty Technologies Inc’s price movement after its last earnings report?
AquaBounty Technologies Inc reported an EPS of -$0.263 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 0.644%.
Which hedge fund is a major shareholder of AquaBounty Technologies Inc?
Currently, no hedge funds are holding shares in AQB
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
AquaBounty Technologies Inc
AquaBounty Technologies, Inc. is a biotechnology firm dedicated to boosting productivity within the commercial fish farming sector across the United States and Canada. The company's research initiatives delve into genetics, genomics, fish health, and nutrition. Its flagship offering is AquAdvantage Salmon, a genetically engineered Atlantic salmon intended for human consumption. Beyond this, AquaBounty also supplies conventional Atlantic salmon, along with salmon eggs, juvenile fish (fry), and various byproducts. Established in 1991, the firm maintains its headquarters in Maynard, Massachusetts. It operated under the name Aqua Bounty Farms, Inc. until its rebranding in June 2004.
Technical Analysis
Ownership Overview
―
Insiders
1.30% Mutual Funds
1.73% Other Institutional Investors
96.52% Public Companies and
Individual Investors